Todas as fotos(1)

Documentos Principais

COO/COA

Visualizar Toda a Documentação

286818

Neostigmine methyl sulfate

Name: Neostigmine methyl sulfate
Brand: ALDRICH

98%

Sinônimo(s):

3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium methyl sulfate

Faça loginpara ver os preços organizacionais e de contrato

Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):

C₁₃H₂₂N₂O₆S

Número CAS:

51-60-5

Peso molecular:

334.39

Número CE:

200-109-5

Número MDL:

MFCD00011796

Código UNSPSC:

12352103

Ensaio

98%

cadeia de caracteres SMILES

COS([O-])(=O)=O.CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C

InChI

1S/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1

chave InChI

OSZNNLWOYWAHSS-UHFFFAOYSA-M

Procurando produtos similares? Visita Guia de comparação de produtos

Ações bioquímicas/fisiológicas

Reversible inhibitor of acetylcholinesterase that is similar to eserine, but does not cross the blood-brain barrier.

Pictogramas

GHS06,GHS08

Palavra indicadora

Danger

Frases de perigo

H300,H315,H319,H334,H335

Declarações de precaução

P261 - P264 - P301 + P310 - P305 + P351 + P338 - P342 + P311

Classificações de perigo

Acute Tox. 2 Oral - Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3

Órgãos-alvo

Respiratory system

Código de classe de armazenamento

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

Classe de risco de água (WGK)

WGK 3

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Equipamento de proteção individual

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Pesquise por COA

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

[Anticholinesterases; peripheral and central effects].

Tetsufumi Sato et al.

Masui. The Japanese journal of anesthesiology, 62(1), 19-26 (2013-02-26)

Anticholinesterase, such as neostigmine, was used to be a standard drug at the end of surgery for reversal of nondepolarizing neuromuscular block. Neostigmine decreases the metabolism of acetylcholine (ACh) at the neuromuscular junction and allows its concentration to increase and

A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery.

G V Cammu et al.

Anaesthesia and intensive care, 40(6), 999-1006 (2012-12-01)

Six years ago, a study performed in our department reported that the incidence of postoperative residual curarisation (PORC) was 39%. The reassessment of neuromuscular monitoring and reversal of neuromuscular block in routine anaesthetic practice is relevant now that sugammadex has

New neostigmine-based behavioral mouse model of abdominal pain.

Jakub Fichna et al.

Pharmacological reports : PR, 64(5), 1146-1154 (2012-12-15)

Animal models of visceral pain have gained much attention as an important tool to elucidate the possible mechanisms underlying functional gastrointestinal (GI) disorders. Here we report the development of a new, minimally invasive behavioral model of abdominal pain induced by

The cholinergic stimulation of the hippocampus induced the activation of the sympathetic nervous system.

Oyun Khookhor et al.

Neuro endocrinology letters, 34(1), 58-61 (2013-03-26)

We previously demonstrated that the direct microinjection of cholinesterase inhibitor (neostigmine) into the hippocampus in rats activated the hypothalamo-pituitary -adrenal axis and increased the level of norepinephrine in the plasma. In the current study we tried to measure the effects

Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study.

Martina Grosse-Sundrup et al.

BMJ (Clinical research ed.), 345, e6329-e6329 (2012-10-19)

To determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the incidence of postoperative respiratory complications. Prospective, propensity score matched cohort study. General teaching hospital in Boston, Massachusetts, United States, 2006-10. 18,579 surgical patients who received

Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica